Title : A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.

Pub. Date : 2018 Jun

PMID : 29567781






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Combination therapy with decitabine, vorinostat and cytarabine was tolerated in younger relapsed/refractory acute myeloid leukemia and should be explored further focusing on the KMT2A partial tandem duplication subset. Decitabine lysine methyltransferase 2A Homo sapiens